These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7792794)
1. Ouabain-inhibiting activity of aldosterone antagonists. Semplicini A; Serena L; Valle R; Ceolotto G; Felice M; Fontebasso A; Pessina AC Steroids; 1995 Jan; 60(1):110-3. PubMed ID: 7792794 [TBL] [Abstract][Full Text] [Related]
2. [Canrenone: an effective antihypertensive in an experimental model of hypertension in which the active transport of sodium is diminished]. Grichois ML; de Mendonça M; Wauquier I; Pernollet MG; Thormann B; Devynck MA; Meyer P; Garay RP Arch Mal Coeur Vaiss; 1986 Jun; 79(6):875-8. PubMed ID: 3099704 [TBL] [Abstract][Full Text] [Related]
3. Ouabain antagonists as antihypertensive agents. Ferrandi M; Barassi P; Molinari I; Torielli L; Tripodi G; Minotti E; Bianchi G; Ferrari P Curr Pharm Des; 2005; 11(25):3301-5. PubMed ID: 16250857 [TBL] [Abstract][Full Text] [Related]
4. Alteration in the sarcolemmal Na(+)-K+ pump of hindquarters resistance arteries in DOCA-salt rats. Yamamoto K; Takeshita A; Ashihara T; Imaizumi T; Nakamura M Clin Exp Hypertens A; 1990; 12(7):1237-54. PubMed ID: 2257689 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic agents for the in vivo detection of vascular sodium transport defects in hypertension. Haddy FJ; Pamnani MB Life Sci; 1987 Dec; 41(25):2685-96. PubMed ID: 2447462 [TBL] [Abstract][Full Text] [Related]
6. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension. Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844 [TBL] [Abstract][Full Text] [Related]
7. PST 2238: a new antihypertensive compound that modulates renal Na-K pump function without diuretic activity in Milan hypertensive rats. Ferrandi M; Barassi P; Minotti E; Duzzi L; Molinari I; Bianchi G; Ferrari P J Cardiovasc Pharmacol; 2002 Dec; 40(6):881-9. PubMed ID: 12451321 [TBL] [Abstract][Full Text] [Related]
8. Increase in the basal tone of guinea pig thoracic aorta induced by ouabain is inhibited by spironolactone canrenone and potassium canrenoate. Sorrentino R; Cirino G; Calignano A; Mancuso F; Sorrentino L; Andriuoli G; Pinto A J Cardiovasc Pharmacol; 1996 Oct; 28(4):519-25. PubMed ID: 8891876 [TBL] [Abstract][Full Text] [Related]
9. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin. Meyer-Lehnert H; Bäcker A; Kramer HJ Am J Hypertens; 2000 Apr; 13(4 Pt 1):364-9. PubMed ID: 10821337 [TBL] [Abstract][Full Text] [Related]
10. The pump, the exchanger, and the holy spirit: origins and 40-year evolution of ideas about the ouabain-Na Blaustein MP Am J Physiol Cell Physiol; 2018 Jan; 314(1):C3-C26. PubMed ID: 28971835 [TBL] [Abstract][Full Text] [Related]
11. Ouabainlike factor in Milan hypertensive rats. Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of a ouabain-like factor from Milan hypertensive rats. Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036 [TBL] [Abstract][Full Text] [Related]
13. Antihypertensive effect of canrenone in a model where endogenous ouabain-like factors are present. de Mendonça M; Grichois ML; Pernollet MG; Wauquier I; Trouillet-Thormann B; Meyer P; Devynck MA; Garay R J Cardiovasc Pharmacol; 1988 Jan; 11(1):75-83. PubMed ID: 2450260 [TBL] [Abstract][Full Text] [Related]
14. Endogenous and exogenous cardiac glycosides and their mechanisms of action. Schoner W; Scheiner-Bobis G Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345 [TBL] [Abstract][Full Text] [Related]
15. Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/ cSRC pathway. Wenceslau CF; Rossoni LV J Hypertens; 2014 Mar; 32(3):542-54. PubMed ID: 24309491 [TBL] [Abstract][Full Text] [Related]
16. Negative inotropic effects of aldosterone antagonists in isolated human and guinea-pig ventricular heart muscle. Mügge A; Schmitz W; Scholz H Klin Wochenschr; 1984 Aug; 62(15):717-23. PubMed ID: 6492693 [TBL] [Abstract][Full Text] [Related]
17. Systemic hypertension: the roles of salt, vascular Na+/K+ ATPase and the endogenous glycosides, ouabain and marinobufagenin. Hauck C; Frishman WH Cardiol Rev; 2012; 20(3):130-8. PubMed ID: 22183064 [TBL] [Abstract][Full Text] [Related]
19. Effects of canrenone on blood pressure in rats with reduced renal mass. Pamnani MB; Whitehorn WV; Clough DL; Haddy FJ Am J Hypertens; 1990 Mar; 3(3):188-95. PubMed ID: 2157466 [TBL] [Abstract][Full Text] [Related]
20. Effect of canrenone on the digitalis site of Na+/K(+)-ATPase in human placental membranes and in erythrocytes. Balzan S; Nicolini G; Bellitto L; Ghione S; Biver P; Montali U J Cardiovasc Pharmacol; 2003 Jul; 42(1):32-6. PubMed ID: 12827023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]